Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMF1-regulated nuclear protein 1 (TRNP1) is a short-lived, low-complexity nuclear DNA-binding protein encoded by the TRNP1 gene. It is crucial for cellular proliferation, especially in neural stem cells, and plays a major role in brain development and cortical folding, acting as a key regulator of gene expression during neurogenesis. TRNP1 interacts with and organizes several nuclear membrane-less compartments, such as nucleoli, nuclear speckles, and heterochromatin; it can self-assemble and phase separate via intrinsically disordered regions to modulate nuclear architecture and cellular functions. TRNP1 levels in the brain correlate with cortical complexity and folding. Disease associations include neurodevelopmental disorders and cancer, where its proliferative capacity may underlie oncogenic potential. No drugs directly target TRNP1 yet, but its unique mechanisms provide future opportunities for therapeutic modulation in brain development and cancer.
Drugs targeting such proteins would likely modulate DNA binding, phase separation, or protein-protein interaction networks relevant for cell proliferation and neural development
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMF1-regulated nuclear protein 1 (TRNP1).